Ermium Therapeutics

Summary

Seedtable Score

37

Locations

• Paris

Company Size

• 1 - 11

Last Stage Round

• Series A

Industry

• Biotech
• Health Tech
• Pharma

Insights

Ermium Therapeutics, based in Paris, shows strong potential in developing treatments for autoimmune diseases. Operating on a B2B model, the company collaborates with biotech and pharmaceutical firms. Their focus on novel solutions sets them apart in a market where current treatments often prove ineffective. Supported by Fountain Healthcare Partners, Ermium Therapeutics is well-positioned to capture market interest and achieve breakthroughs in challenging health conditions.

• Series A (2022-01-01) $6.0M

---

Investors

• Fountain Healthcare Partners Series A

---